Thermo Fisher Scientific Inc. has acquired Core Informatics, provider of cloud-based platform that supports scientific data management
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Sophia Genetics set to break through the strategic threshold of 100K patients’ genomic profiles analyzed by its artificial intelligence SOPHiA
Sophia Genetics officially cross the strategic threshold of analyzing genomic profiles from 100K patients with its artificial intelligence SOPHiA
A very special drug, whose development was guided by artificial intelligence to treat a rare form of brain cancer has moved into a phase I/II clinical trial
Garvan Institute of Medical Research to integrate Geneformics technology Into its genomic data storage and archive workflows for research
New advistory board comprises experts for Cambridge Epigenetix’s key focus areas, including oncology, liquid biopsy and ageing
Freenome, a health technology company specialising in liquid biopsy, has raised $65 million USD in Series A funding
UK-based genome analysis startup Congenica have announced the completion of a Series B financing round, to the tune of £8M ($10M).
MIODx has signed an exclusive license for two key immunotherapy technologies from the University of California, San Francisco
John Thompson is to join the board of directors at Illumina, bringing extensive technology leadership experience to the company
A small number of biotech firms could hold sole control for the future of CRISPR innovation
USPTO upholds Broad Institute patents for CRISPR/Cas9 gene editing, a substantial blow UC Berkeley attempts to overturn them
Diagnostic test specialists Invivoscribe have announced a new partnership with Illumina to develop IVD assays for Illumina’s FDA-approved NGS platform